Teleflex (TFX)
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$138.36-1.14%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · TFX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 2,600.6 | 1,992.7 | 3,047.3 | 1,712.4 | 2,791.0 | 2,809.6 | 2,537.2 | 2,595.4 | 2,448.4 | 2,146.3 | 1,868.0 | 1,809.7 | 1,839.8 | 1,696.3 | 1,551.0 | 1,492.5 | 1,397.7 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 2,146.3 | 1,868.0 | 1,809.7 | 1,839.8 | 1,696.3 | 1,551.0 | 1,492.5 | 1,397.7 |
| Cost of Revenues | 1,015.9 | 872.0 | 1,344.6 | 672.3 | 1,260.0 | 1,260.0 | 1,212.3 | 1,186.4 | 1,145.6 | — | — | — | — | — | — | — | — |
| Gross Profit | 1,398.2 | 1,120.8 | 1,702.7 | 1,040.1 | 1,531.1 | 1,549.6 | 1,324.9 | 1,409.0 | 1,302.8 | 1,171.8 | 996.2 | 944.4 | 942.4 | 838.9 | 748.2 | 708.8 | 678.8 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 869.3 | 720.2 | 995.3 | 622.7 | 863.7 | 860.1 | 743.6 | 851.8 | 797.1 | 700.0 | 563.3 | 569.0 | 578.7 | 502.2 | 454.5 | 423.9 | 403.6 |
| R&D Expenses | 182.5 | 144.8 | 161.7 | 113.6 | 153.8 | 130.8 | 119.7 | 113.9 | 106.2 | 84.8 | 58.6 | 52.1 | 61.0 | 65.0 | 56.3 | 48.7 | 42.4 |
| Operating Income | (302.0) | 118.4 | 151.0 | 258.7 | 499.7 | 628.1 | 423.1 | 427.3 | 321.7 | 372.3 | 319.5 | 315.9 | 284.9 | 233.3 | (97.4) | 229.6 | 230.3 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | 100.2 | 83.5 | 85.1 | 54.3 | 57.0 | 66.5 | 80.3 | 103.0 | 82.5 | 54.9 | 61.3 | 65.5 | 56.9 | 69.6 | 70.3 | 79.8 |
| Interest & Investment Income | 6.8 | 6.4 | 8.0 | 11.7 | 0.9 | 1.3 | 1.2 | 1.7 | 0.9 | 0.8 | 0.5 | 0.5 | 0.7 | 0.6 | 1.6 | 1.3 | 0.7 |
| Net Interest Expenses | — | — | — | 73.4 | 53.4 | 55.6 | 65.3 | 78.5 | 102.1 | 81.8 | 54.5 | 60.8 | 64.8 | 56.3 | 68.0 | 69.1 | 79.1 |
| Asset Writedown | — | 108.1 | 7.8 | 0.0 | 1.5 | 6.7 | 21.4 | 7.0 | 19.1 | 43.4 | 43.4 | 0.0 | 10.8 | 2.5 | 2.5 | 2.5 | — |
| EBT, Incl. Unusual Items | (63.6) | 24.6 | 75.5 | 185.4 | 445.9 | 559.5 | 357.7 | 339.9 | 219.6 | 284.9 | 245.7 | 244.6 | (97.4) | 175.7 | (165.4) | 145.1 | 130.4 |
| Income Tax Expense | (38.5) | (34.0) | 5.3 | 41.9 | 83.0 | 74.3 | 21.9 | (122.1) | 23.2 | 129.6 | 8.1 | 7.8 | 28.7 | 23.5 | 16.4 | 25.8 | 16.9 |
| Earnings from Continuing Operations | (375.5) | 58.5 | 70.2 | 143.5 | 362.9 | 485.1 | 335.8 | 462.0 | 196.4 | 155.3 | 237.7 | 236.8 | 191.5 | 152.2 | (181.8) | 119.3 | 87.7 |
| Net Income | |||||||||||||||||
| Net Income | (1,031.7) | (905.6) | 69.7 | 357.6 | 363.1 | 485.4 | 335.3 | 461.5 | 200.8 | 152.5 | 237.4 | 244.9 | 187.7 | 150.9 | (190.1) | 323.3 | 201.1 |
| Per Share | |||||||||||||||||
| Basic EPS | (23.68) | (20.30) | 1.49 | 7.58 | 7.74 | 10.38 | 7.21 | 9.99 | 4.39 | 3.39 | 5.48 | 5.89 | 4.54 | 3.67 | (4.65) | 7.98 | 5.04 |
| Diluted EPS | (23.63) | (20.25) | 1.48 | 7.53 | 7.68 | 10.23 | 7.09 | 9.80 | 4.29 | 3.27 | 4.98 | 5.10 | 4.04 | 3.45 | (4.65) | 7.92 | 4.99 |
| Revenue per Share | 59.56 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 |
| Basic Weighted Avg Shares | 43.6 | 44.6 | 46.8 | 47.0 | 46.9 | 46.8 | 46.5 | 46.2 | 45.7 | 45.0 | 43.3 | 41.6 | 41.4 | 41.1 | 40.9 | 40.5 | 39.9 |
| Diluted Weighted Avg Shares | 43.7 | 44.7 | 47.1 | 47.3 | 47.3 | 47.4 | 47.3 | 47.1 | 46.8 | 46.7 | 47.6 | 48.1 | 46.5 | 43.7 | 40.9 | 40.8 | 40.3 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 296.1 | 425.6 | 406.8 | 730.3 | 865.5 | 650.3 | 645.6 | 536.4 | 532.6 | 447.8 | 441.2 | 411.9 | — | (2.5) | — | — |
| EBIT | (302.0) | 118.4 | 151.0 | 258.7 | 499.7 | 628.1 | 423.1 | 427.3 | 321.7 | 372.3 | 319.5 | 315.9 | 284.9 | 233.3 | (97.4) | 229.6 | 230.3 |
| Effective Tax Rate | 60.6% | — | — | 22.6% | 18.6% | 13.3% | 6.1% | -35.9% | 10.6% | 45.5% | 3.3% | 3.2% | -29.4% | 13.4% | -9.9% | 17.8% | 13.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.